474 related articles for article (PubMed ID: 27463014)
1. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance.
Colombo M; Garavelli S; Mazzola M; Platonova N; Giannandrea D; Colella R; Apicella L; Lancellotti M; Lesma E; Ancona S; Palano MT; Barbieri M; Taiana E; Lazzari E; Basile A; Turrini M; Pistocchi A; Neri A; Chiaramonte R
Haematologica; 2020 Jul; 105(7):1925-1936. PubMed ID: 31582544
[TBL] [Abstract][Full Text] [Related]
4. Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma.
Takeuchi T; Adachi Y; Ohtsuki Y
Am J Pathol; 2005 Jun; 166(6):1817-26. PubMed ID: 15920166
[TBL] [Abstract][Full Text] [Related]
5. Notch signaling drives multiple myeloma induced osteoclastogenesis.
Colombo M; Thümmler K; Mirandola L; Garavelli S; Todoerti K; Apicella L; Lazzari E; Lancellotti M; Platonova N; Akbar M; Chiriva-Internati M; Soutar R; Neri A; Goodyear CS; Chiaramonte R
Oncotarget; 2014 Nov; 5(21):10393-406. PubMed ID: 25257302
[TBL] [Abstract][Full Text] [Related]
6. Jagged1 promotes mineralization in human bone-derived cells.
Osathanon T; Manokawinchoke J; Sa-Ard-Iam N; Mahanonda R; Pavasant P; Suwanwela J
Arch Oral Biol; 2019 Mar; 99():134-140. PubMed ID: 30682716
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
8. Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes.
Colombo M; Mirandola L; Platonova N; Apicella L; Basile A; Figueroa AJ; Cobos E; Chiriva-Internati M; Chiaramonte R
Leukemia; 2013 Apr; 27(5):1009-18. PubMed ID: 23307030
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling in T cells is essential for allergic airway inflammation, but expression of the Notch ligands Jagged 1 and Jagged 2 on dendritic cells is dispensable.
Tindemans I; Lukkes M; de Bruijn MJW; Li BWS; van Nimwegen M; Amsen D; KleinJan A; Hendriks RW
J Allergy Clin Immunol; 2017 Oct; 140(4):1079-1089. PubMed ID: 28111308
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Global and Jagged-Mediated Notch Signaling Disrupts Segregation Between wt1-Expressing and Steroidogenic Tissues in Zebrafish.
Chou CW; Lin J; Jiang YJ; Liu YW
Endocrinology; 2017 Dec; 158(12):4206-4217. PubMed ID: 29029162
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling deregulation in multiple myeloma: A rational molecular target.
Colombo M; Galletti S; Garavelli S; Platonova N; Paoli A; Basile A; Taiana E; Neri A; Chiaramonte R
Oncotarget; 2015 Sep; 6(29):26826-40. PubMed ID: 26308486
[TBL] [Abstract][Full Text] [Related]
13. Ligand-dependent Notch signaling strength orchestrates lateral induction and lateral inhibition in the developing inner ear.
Petrovic J; Formosa-Jordan P; Luna-Escalante JC; Abelló G; Ibañes M; Neves J; Giraldez F
Development; 2014 Jun; 141(11):2313-24. PubMed ID: 24821984
[TBL] [Abstract][Full Text] [Related]
14. Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity.
Tchekneva EE; Goruganthu MUL; Uzhachenko RV; Thomas PL; Antonucci A; Chekneva I; Koenig M; Piao L; Akhter A; de Aquino MTP; Ranganathan P; Long N; Magliery T; Valujskikh A; Evans JV; Arasada RR; Massion PP; Carbone DP; Shanker A; Dikov MM
J Immunother Cancer; 2019 Apr; 7(1):95. PubMed ID: 30940183
[TBL] [Abstract][Full Text] [Related]
15. The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma.
Platonova N; Lazzari E; Colombo M; Falleni M; Tosi D; Giannandrea D; Citro V; Casati L; Ronchetti D; Bolli N; Neri A; Torricelli F; Crews LA; Jamieson CHM; Chiaramonte R
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834003
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
17. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells.
Cahill EF; Tobin LM; Carty F; Mahon BP; English K
Stem Cell Res Ther; 2015 Mar; 6(1):19. PubMed ID: 25890330
[TBL] [Abstract][Full Text] [Related]
18. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
Guo S; Gonzalez-Perez RR
PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation.
Fernandez L; Rodriguez S; Huang H; Chora A; Fernandes J; Mumaw C; Cruz E; Pollok K; Cristina F; Price JE; Ferkowicz MJ; Scadden DT; Clauss M; Cardoso AA; Carlesso N
Exp Hematol; 2008 May; 36(5):545-558. PubMed ID: 18439488
[TBL] [Abstract][Full Text] [Related]
20. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
